Oral treatment with a potential probiotic (Enterococcus faecalis CECT 7121) appears to reduce the parasite burden of mice infected with Toxocara canis.
Basualdo
J
J
Department of Microbiology and Parasitology, School of Medical Sciences, Universidad Nacional de La Plata, Calles 60 y 120, La Plata (1900), Argentina. jabasua@atlas.med.unlp.edu.ar
Sparo
M
M
Chiodo
P
P
Ciarmela
M
M
Minvielle
M
M
D000818:Animals; D013293:Enterococcus faecalis / Q000254:growth & development*; D051379:Mice; D019936:Probiotics / Q000627:therapeutic use*; D017166:Toxocara canis / Q000469:parasitology; D014120:Toxocariasis / Q000628:therapy*